Financials IHH Healthcare

Equities

IHH

MYL5225OO007

Healthcare Facilities & Services

End-of-day quote BURSA MALAYSIA 06:00:00 2024-04-25 pm EDT 5-day change 1st Jan Change
6.27 MYR +0.32% Intraday chart for IHH Healthcare +2.45% +3.98%

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 47,994 48,275 64,568 54,774 53,106 55,220 - -
Enterprise Value (EV) 1 52,305 53,770 70,083 54,774 53,106 62,073 61,723 61,894
P/E ratio 104 x 242 x 36.3 x 36.6 x 18 x 31.5 x 28.8 x 24.5 x
Yield 0.73% 0.73% 0.82% - - 1.27% 1.37% 1.45%
Capitalization / Revenue 3.22 x 3.6 x 3.77 x 3.04 x 2.54 x 2.5 x 2.34 x 2.19 x
EV / Revenue 3.51 x 4.01 x 4.09 x 3.04 x 2.54 x 2.81 x 2.62 x 2.46 x
EV / EBITDA 15.8 x 18.7 x 16.4 x 13.5 x 11.4 x 12.5 x 11.6 x 10.8 x
EV / FCF 37.6 x 34.2 x 28 x - - 31.3 x 26 x 19.1 x
FCF Yield 2.66% 2.92% 3.57% - - 3.19% 3.85% 5.23%
Price to Book 2.15 x 2.02 x 2.63 x - - 1.86 x 1.79 x 1.66 x
Nbr of stocks (in thousands) 8,773,990 8,777,219 8,796,677 8,806,043 8,806,991 8,806,992 - -
Reference price 2 5.470 5.500 7.340 6.220 6.030 6.270 6.270 6.270
Announcement Date 2/28/20 2/26/21 2/23/22 2/28/23 2/29/24 - - -
1MYR in Million2MYR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 14,912 13,405 17,132 17,989 20,935 22,061 23,582 25,191
EBITDA 1 3,318 2,876 4,279 4,051 4,644 4,947 5,304 5,708
EBIT 1 1,962 1,479 2,795 2,260 3,133 3,249 3,542 3,848
Operating Margin 13.16% 11.03% 16.32% 12.57% 14.97% 14.73% 15.02% 15.28%
Earnings before Tax (EBT) 1 1,043 567.5 2,556 2,217 4,049 2,716 3,080 3,474
Net income 1 551.5 288.9 1,863 1,548 2,952 1,730 1,917 2,178
Net margin 3.7% 2.16% 10.87% 8.61% 14.1% 7.84% 8.13% 8.64%
EPS 2 0.0528 0.0227 0.2020 0.1699 0.3352 0.1989 0.2174 0.2559
Free Cash Flow 1 1,391 1,571 2,504 - - 1,981 2,378 3,240
FCF margin 9.33% 11.72% 14.62% - - 8.98% 10.08% 12.86%
FCF Conversion (EBITDA) 41.92% 54.6% 58.52% - - 40.05% 44.83% 56.75%
FCF Conversion (Net income) 252.2% 543.67% 134.47% - - 114.5% 124.02% 148.76%
Dividend per Share 2 0.0400 0.0400 0.0600 - - 0.0799 0.0857 0.0911
Announcement Date 2/28/20 2/26/21 2/23/22 2/28/23 2/29/24 - - -
1MYR in Million2MYR
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales 1 4,445 4,471 4,163 4,374 4,595 4,857 5,142 4,674 5,826 5,293 5,102 5,487 5,707 5,268 5,764
EBITDA - - - - - - 1,149 - - - - - - - -
EBIT 1 733.6 791.2 686.6 632.7 652.7 324.3 780 666.7 1,004 682.6 748.5 873.6 908.6 838.7 982.3
Operating Margin 16.5% 17.7% 16.49% 14.47% 14.2% 6.68% 15.17% 14.26% 17.23% 12.9% 14.67% 15.92% 15.92% 15.92% 17.04%
Earnings before Tax (EBT) 1 616.6 684.2 621.1 878.5 513.3 204.2 1,793 542 1,013 701.6 709.2 709.2 744.5 673.9 825.3
Net income 1 550 453.6 493.3 612.1 251.8 191.3 1,391 301.8 532.1 727.5 437.4 437.4 472.8 402.1 505.7
Net margin 12.37% 10.15% 11.85% 14% 5.48% 3.94% 27.04% 6.46% 9.13% 13.74% 8.57% 7.97% 8.28% 7.63% 8.77%
EPS 2 0.0601 0.0490 0.0535 0.0669 0.0278 0.0217 0.1579 0.0343 0.0604 0.0826 0.0498 0.0498 0.0538 0.0458 0.0576
Dividend per Share 2 - 0.0600 - - - - - 0.0350 - - 0.0239 0.0239 0.0249 0.0269 0.0276
Announcement Date 11/29/21 2/23/22 5/26/22 8/25/22 11/29/22 2/28/23 5/31/23 8/29/23 11/30/23 2/29/24 - - - - -
1MYR in Million2MYR
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 4,311 5,496 5,515 - - 6,853 6,503 6,674
Net Cash position 1 - - - - - - - -
Leverage (Debt/EBITDA) 1.299 x 1.911 x 1.289 x - - 1.385 x 1.226 x 1.169 x
Free Cash Flow 1 1,391 1,571 2,504 - - 1,981 2,378 3,240
ROE (net income / shareholders' equity) 3.78% 3% 7.68% - - 6.02% 6.3% 6.86%
ROA (Net income/ Total Assets) 2.04% 1.6% 4.14% - - 4.16% 4.34% 4.96%
Assets 1 26,978 18,055 45,022 - - 41,639 44,224 43,869
Book Value Per Share 2 2.550 2.720 2.790 - - 3.370 3.510 3.780
Cash Flow per Share 2 0.2800 0.2800 0.4000 - - 0.4000 0.4300 0.7000
Capex 1 1,057 874 1,027 - - 2,018 1,953 2,078
Capex / Sales 7.09% 6.52% 6% - - 9.15% 8.28% 8.25%
Announcement Date 2/28/20 2/26/21 2/23/22 2/28/23 2/29/24 - - -
1MYR in Million2MYR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
20
Last Close Price
6.27 MYR
Average target price
7.13 MYR
Spread / Average Target
+13.72%
Consensus
  1. Stock Market
  2. Equities
  3. IHH Stock
  4. Financials IHH Healthcare